Citadel Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-101,329
| Closed | -$468K | – | 10296 |
|
|
2019
Q1 | $468K | Buy |
+101,329
| New | +$480K | ﹤0.01% | 6904 |
|
|
2018
Q2 | – | Sell |
-64,978
| Closed | -$453K | – | 9550 |
|
|
2018
Q1 | $392K | Sell |
64,978
-92,868
| -59% | -$767K | ﹤0.01% | 6297 |
|
|
2017
Q4 | $1.52M | Sell |
157,846
-25,900
| -14% | -$170K | ﹤0.01% | 4016 |
|
|
2017
Q3 | $1.63M | Buy |
183,746
+112,338
| +157% | +$1.16M | ﹤0.01% | 3654 |
|
|
2017
Q2 | $903K | Buy |
71,408
+53,310
| +295% | +$631K | ﹤0.01% | 4233 |
|
|
2017
Q1 | $190K | Sell |
18,098
-54,488
| -75% | -$581K | ﹤0.01% | 6562 |
|
|
2016
Q4 | $668K | Sell |
72,586
-315,097
| -81% | -$3.56M | ﹤0.01% | 4458 |
|
|
2016
Q3 | $4.57M | Buy |
+387,683
| New | +$5.89M | ﹤0.01% | 2073 |
|
|
2016
Q1 | – | Sell |
-446,129
| Closed | -$8.47M | – | 8592 |
|
|
2015
Q4 | $12.8M | Sell |
446,129
-520,288
| -54% | -$14.4M | 0.01% | 1099 |
|
|
2015
Q3 | $27.5M | Buy |
966,417
+767,504
| +386% | +$28.2M | 0.03% | 706 |
|
|
2015
Q2 | $7.14M | Buy |
198,913
+52,997
| +36% | +$1.65M | 0.01% | 1720 |
|
|
2015
Q1 | $4.24M | Buy |
145,916
+118,510
| +432% | +$3.13M | ﹤0.01% | 2196 |
|
|
2014
Q4 | $577K | Sell |
27,406
-19,386
| -41% | -$383K | ﹤0.01% | 4518 |
|
|
2014
Q3 | $907K | Sell |
46,792
-18,230
| -28% | -$286K | ﹤0.01% | 3831 |
|
|
2014
Q2 | $1.01M | Buy |
65,022
+28,370
| +77% | +$459K | ﹤0.01% | 3468 |
|
|
2014
Q1 | $760K | Sell |
36,652
-67,253
| -65% | -$1.33M | ﹤0.01% | 3779 |
|
|
2013
Q4 | $1.34M | Buy |
103,905
+77,232
| +290% | +$1.07M | ﹤0.01% | 2929 |
|
|
2013
Q3 | $311K | Buy |
+26,673
| New | +$219K | ﹤0.01% | 4305 |
|
Other funds holding INSY
WS
Citadel Advisors's INSY Position: Q2 2019 in Review
Citadel Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 101,329 shares — an estimated $468K sold.
Citadel Advisors first reported a position in INSY in Q3 2013 and held it in 18 quarters. The position peaked at $27.5M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Citadel Advisors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Citadel Advisors sold 101,329 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $468K.
- Citadel Advisors first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 18 quarters.
- Citadel Advisors's Insys Therapeutics, Inc. position peaked at $27.5M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.